東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/05/29 | 2,273 | 2,290 | 2,248 | 2,267 | -6 | -0.3% | 122,000 |
2020/05/28 | 2,255 | 2,285 | 2,241 | 2,273 | +41 | +1.8% | 128,000 |
2020/05/27 | 2,200 | 2,236 | 2,180 | 2,232 | +7 | +0.3% | 116,200 |
2020/05/26 | 2,225 | 2,230 | 2,200 | 2,225 | +29 | +1.3% | 72,000 |
2020/05/25 | 2,216 | 2,216 | 2,174 | 2,196 | +14 | +0.6% | 49,800 |
2020/05/22 | 2,212 | 2,212 | 2,181 | 2,182 | -31 | -1.4% | 79,100 |
2020/05/21 | 2,208 | 2,216 | 2,163 | 2,213 | -3 | -0.1% | 70,500 |
2020/05/20 | 2,182 | 2,217 | 2,158 | 2,216 | +29 | +1.3% | 111,400 |
2020/05/19 | 2,216 | 2,230 | 2,170 | 2,187 | +7 | +0.3% | 107,700 |
2020/05/18 | 2,116 | 2,183 | 2,116 | 2,180 | +29 | +1.3% | 146,200 |
2020/05/15 | 2,222 | 2,240 | 2,141 | 2,151 | -145 | -6.3% | 221,800 |
2020/05/14 | 2,331 | 2,340 | 2,293 | 2,296 | -58 | -2.5% | 83,500 |
2020/05/13 | 2,306 | 2,367 | 2,300 | 2,354 | +33 | +1.4% | 93,900 |
2020/05/12 | 2,303 | 2,339 | 2,301 | 2,321 | +31 | +1.4% | 97,100 |
2020/05/11 | 2,300 | 2,319 | 2,280 | 2,290 | -10 | -0.4% | 89,500 |
2020/05/08 | 2,299 | 2,311 | 2,276 | 2,300 | +11 | +0.5% | 74,500 |
2020/05/07 | 2,275 | 2,310 | 2,263 | 2,289 | +31 | +1.4% | 150,600 |
2020/05/01 | 2,292 | 2,330 | 2,240 | 2,258 | +44 | +2% | 187,300 |
2020/04/30 | 2,251 | 2,291 | 2,214 | 2,214 | -13 | -0.6% | 88,100 |
2020/04/28 | 2,229 | 2,231 | 2,199 | 2,227 | +5 | +0.2% | 47,400 |
2020/04/27 | 2,228 | 2,229 | 2,191 | 2,222 | +11 | +0.5% | 72,300 |
2020/04/24 | 2,220 | 2,222 | 2,190 | 2,211 | +20 | +0.9% | 110,800 |
2020/04/23 | 2,121 | 2,191 | 2,121 | 2,191 | +63 | +3% | 130,500 |
2020/04/22 | 2,121 | 2,131 | 2,087 | 2,128 | -26 | -1.2% | 113,000 |
2020/04/21 | 2,140 | 2,170 | 2,127 | 2,154 | -36 | -1.6% | 129,600 |
2020/04/20 | 2,194 | 2,210 | 2,169 | 2,190 | -1 | ±0% | 76,100 |
2020/04/17 | 2,228 | 2,245 | 2,185 | 2,191 | -54 | -2.4% | 101,100 |
2020/04/16 | 2,195 | 2,247 | 2,180 | 2,245 | +29 | +1.3% | 86,100 |
2020/04/15 | 2,240 | 2,240 | 2,167 | 2,216 | -31 | -1.4% | 170,400 |
2020/04/14 | 2,276 | 2,297 | 2,240 | 2,247 | -20 | -0.9% | 78,400 |
2020/04/13 | 2,285 | 2,304 | 2,252 | 2,267 | -12 | -0.5% | 79,500 |
2020/04/10 | 2,215 | 2,287 | 2,205 | 2,279 | +33 | +1.5% | 74,200 |
2020/04/09 | 2,208 | 2,258 | 2,192 | 2,246 | -7 | -0.3% | 74,200 |
2020/04/08 | 2,196 | 2,285 | 2,194 | 2,253 | +49 | +2.2% | 133,100 |
2020/04/07 | 2,179 | 2,229 | 2,125 | 2,204 | +16 | +0.7% | 115,100 |
2020/04/06 | 2,135 | 2,199 | 2,103 | 2,188 | +64 | +3% | 89,100 |
2020/04/03 | 2,144 | 2,240 | 2,104 | 2,124 | -58 | -2.7% | 122,400 |
2020/04/02 | 2,178 | 2,249 | 2,164 | 2,182 | +2 | +0.1% | 114,500 |
2020/04/01 | 2,217 | 2,276 | 2,165 | 2,180 | -87 | -3.8% | 116,200 |
2020/03/31 | 2,379 | 2,395 | 2,256 | 2,267 | -118 | -4.9% | 151,800 |
2020/03/30 | 2,300 | 2,388 | 2,266 | 2,385 | +35 | +1.5% | 177,200 |
2020/03/27 | 2,338 | 2,380 | 2,290 | 2,350 | +109 | +4.9% | 206,600 |
2020/03/26 | 2,190 | 2,300 | 2,075 | 2,241 | +51 | +2.3% | 235,500 |
2020/03/25 | 2,213 | 2,213 | 2,100 | 2,190 | +77 | +3.6% | 153,900 |
2020/03/24 | 2,149 | 2,163 | 2,046 | 2,113 | +14 | +0.7% | 202,700 |
2020/03/23 | 2,245 | 2,245 | 2,056 | 2,099 | -50 | -2.3% | 399,800 |
2020/03/19 | 2,032 | 2,189 | 2,004 | 2,149 | +199 | +10.2% | 292,000 |
2020/03/18 | 1,944 | 2,043 | 1,931 | 1,950 | +30 | +1.6% | 211,800 |
2020/03/17 | 1,765 | 1,936 | 1,749 | 1,920 | +118 | +6.5% | 227,800 |
2020/03/16 | 1,857 | 1,897 | 1,802 | 1,802 | -53 | -2.9% | 121,000 |
1101~
1150
件表示中 / 6839件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 282,000円 | +15.0% | -7.3% | 2.13% | 9.25倍 | 0.87倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
科研薬 | 446,100円 | +22.8% | +113.0% | 4.26% | 11.90倍 | 1.09倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 365,500円 | +14.5% | -2.3% | 2.46% | 13.37倍 | 0.71倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
ジーエヌアイ | 281,400円 | +52.1% | +23.3% | 0.00% | 19.98倍 | 3.83倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 476,000円 | +12.0% | +28.1% | 2.52% | 26.24倍 | 1.11倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム